Table 2.
Critical appraisal of therapeutic studies.
| Author | Year of publication |
Study design |
Number of participants |
Level of evidence |
Validity | Importance | Applicability | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Randomization | Allocation concealment |
Intention-to-treat | Blinding | Comparable treatment |
Similarity treatment & control |
Clinical importance |
Statistical significance∗ |
Precision of Treatment effect |
Domain | Feasibility of treatment |
Benefit overweighs harm |
|||||
| Davidson et al. [5] | 2015 | RCT | 38 | 2 | + | ? | + | ? | + | + | ? | ? | + | - | - | + |
| Kim et al. [7] | 2016 | RCT | 95 | 2 | + | - | - | - | + | + | - | - | + | - | - | + |
| Bobrow et al. [8] | 2016 | RCT | 1157 | 2 | + | + | + | + | + | + | - | + | - | - | + | + |
| Varleta et al. [6] | 2017 | RCT | 291 | 2 | + | + | + | + | + | + | + | + | + | + | + | + |
| Contreras et al. [9] | 2018 | RCT | 148 | 2 | + | + | + | + | + | + | + | + | + | - | + | + |
+ means present; - means absent; ? means unclear/not mentioned; ∗ means statistical significance at p<0.05.